After pausing a trial for a Moderna-partnered cystic fibrosis candidate due to subpar tolerability, Vertex Pharmaceuticals ...

Vertex Pharmaceuticals halted a cystic fibrosis program in the works with Moderna over lung inflammation concerns. The ...

As online sales transactions increase in volume year after year, companies that provide tax automation are seeing a major increase in the need for their services. Vertex is one of those companies, and ...

Vertex, BioMarin, and IQVIA reported Q1 2026 results showing revenue growth but varied earnings outcomes. Vertex posted 8% revenue growth to $2.99 billion, BioMarin saw a 3% revenue rise but missed ...

The program, Vertex Certified, uses a remote, Web-based learning format for learning the company's corporate tax software system, reducing travel costs. It provides organizations with a clear way to ...

King of Prussia-based Vertex plans to reduce its workforce by nine percent, as the tax and compliance software maker pivots ...

It had been 11 years since Noah Hoffman ’22 had taken a math class when he arrived on campus this fall. A Resumed Undergraduate Education student and former Olympic cross-country skier, Hoffman ...

NEW YORK and ROME, Ga., Aug. 5, 2025 /PRNewswire/ -- The VERTEX Companies, LLC ("VERTEX"), a global professional services firm delivering expert, forensic, construction project advisory, and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

- VX-264 Phase 1/2 enrollment and dosing complete in Parts A and B: VX-264 was generally safe and well tolerated; efficacy data are not supportive of further clinical advancement - - Zimislecel ...

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment, and that business generates billions of dollars in annual revenue. The biotech has treatment candidate in another indication ...